Table 4 Summary of the occurrence of adverse events
Adverse events | Group C (n = 19) | Group U (n = 21) | Group F (n = 21) |
|---|---|---|---|
High blood pressure | 10 | 6 | 1†|
Tachycardia | 9 | 9 | 4 |
Low blood pressure | 0 | 3 | 0 |
Bradycardia | 0 | 0 | 0 |
Throat bleeding | 0 | 4 | 0 |
Adverse events | Group C (n = 19) | Group U (n = 21) | Group F (n = 21) |
|---|---|---|---|
High blood pressure | 10 | 6 | 1†|
Tachycardia | 9 | 9 | 4 |
Low blood pressure | 0 | 3 | 0 |
Bradycardia | 0 | 0 | 0 |
Throat bleeding | 0 | 4 | 0 |